Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease

doi:10.3748/wjg.v17.i27.3235

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 27

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2708)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

249

HTML

1941

Figures (1-4)

289

Tables (1-2)

229

Sum=2708

Jul 21, 2011 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jul 21, 2011; 17(27): 3235-3241
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3235

Full Size Figure Download Figure

Figure 2 Subgroups of gastroesophageal reflux disease patients according to esophagitis and irritable bowel syndrome-like symptoms. Percentages do not equal 100% due to missing values. ^aP = 0.0015, irritable bowel syndrome (IBS)-like +: patients with non-erosive reflux disease (NERD) vs patients with erosive (ERD). n: Number of patients; GERD: Gastroesophageal reflux disease.

Citation: Mönnikes H, Heading RC, Schmitt H, Doerfler H. Influence of irritable bowel syndrome on treatment outcome in gastroesophageal reflux disease. World J Gastroenterol 2011; 17(27): 3235-3241
URL: https://www.wjgnet.com/1007-9327/full/v17/i27/3235.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i27.3235